A Case of Anti-Caspr2 Autoimmune Encephalitis Associated with Adenocarcinoma of the Lung
- PMID: 36506746
- PMCID: PMC9728219
- DOI: 10.12890/2022_003544
A Case of Anti-Caspr2 Autoimmune Encephalitis Associated with Adenocarcinoma of the Lung
Abstract
Autoimmune encephalitis (AIE) is an inflammatory brain condition with multiple aetiologies but is mainly associated with paraneoplastic syndromes. Several antibodies described in AIE are being investigated in relation to different cancers, including antibodies against Contactin-associated protein-like 2 (Caspr2), which have been associated with thymoma but very rarely with lung cancer. The authors present the case of a 72-year-old man with cardiovascular risk factors, who presented with a 3-week history of left hemichorea following a first unprovoked seizure the week before, with no other signs or symptoms. The patient was submitted to extensive aetiological investigation, testing positive for anti-Caspr2 antibodies in the cerebrospinal fluid. AIE was diagnosed after other possible causes had been excluded. A PET scan showed signs of abnormal metabolism, with a lung biopsy confirming lung adenocarcinoma. This case highlights a very rare association and the importance of a thorough aetiological investigation for neurological complaints.
Learning points: Neurological complaints require a thorough aetiological investigation, and positive findings on imaging studies must be carefully examined.Anti-Caspr2 antibodies are classically associated with Morvan syndrome, but other neurological presentations must also be considered.Anti-Caspr2 autoimmune encephalitis may be the primary presentation of lung adenocarcinoma.
Keywords: Autoimmune encephalitis; anti-Caspr2; lung adenocarcinoma; paraneoplastic syndrome.
© EFIM 2022.
Conflict of interest statement
Conflicts of Interests: The authors declare there are no competing interests.
Similar articles
-
Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures.JAMA Neurol. 2016 Sep 1;73(9):1115-24. doi: 10.1001/jamaneurol.2016.1585. JAMA Neurol. 2016. PMID: 27428927
-
Systematic review of the clinical spectrum of CASPR2 antibody syndrome.J Neurol. 2020 Apr;267(4):1137-1146. doi: 10.1007/s00415-019-09686-2. Epub 2020 Jan 7. J Neurol. 2020. PMID: 31912210
-
Case report: Autoimmune encephalitis associated with anti-CASPR2 antibody mimicking cerebral infarction.Front Immunol. 2023 Jan 26;14:1041664. doi: 10.3389/fimmu.2023.1041664. eCollection 2023. Front Immunol. 2023. PMID: 36776888 Free PMC article.
-
Autoimmune neuromyotonia.Curr Opin Neurol. 2022 Oct 1;35(5):597-603. doi: 10.1097/WCO.0000000000001104. Epub 2022 Aug 19. Curr Opin Neurol. 2022. PMID: 35989569 Review.
-
Distinct phenotypes in a cohort of anti-CASPR2 associated neurological syndromes.Clin Neurol Neurosurg. 2023 Nov;234:107994. doi: 10.1016/j.clineuro.2023.107994. Epub 2023 Sep 30. Clin Neurol Neurosurg. 2023. PMID: 37797365
Cited by
-
Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome.Front Immunol. 2023 Sep 18;14:1243946. doi: 10.3389/fimmu.2023.1243946. eCollection 2023. Front Immunol. 2023. PMID: 37795104 Free PMC article.
References
-
- Boyko M, Au K, Casault C, de Robles P, Pfeffer G. Systematic review of the clinical spectrum of CASPR2 antibody syndrome. J Neurol. 2020;267(4):1137–1146. - PubMed
LinkOut - more resources
Full Text Sources